Hyperphosphatemia in pediatric oncology patients receiving liposomal amphotericin B
{{output}}
Objective: After transitioning our front-line amphotericin product to the liposomal formulation, we observed an increased incidence of hyperphosphatemia. We aimed to determine the incidence of hyperphosphatemia in children with o... ...
